CREATE Medicines

Cambridge, United States

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

May 2026

Series B

Biotechnology Life Science Therapeutics

Top Investors

ARCH Venture Partners8VCHatteras Venture PartnersNewpath ManagementAlexandria Venture Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CREATE Medicines

Who are CREATE Medicines's investors?

CREATE Medicines's investors include ARCH Venture Partners, 8VC, Hatteras Venture Partners, Newpath Management, Alexandria Venture Investments.

Where is CREATE Medicines headquartered?

CREATE Medicines is headquartered in Cambridge, United States.

What does CREATE Medicines do?

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

What stage is CREATE Medicines at?

CREATE Medicines is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 14, 2026.

MLA

"CREATE Medicines — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/create-medicines. Accessed June 3, 2026.

APA

VCBacked. (2026). CREATE Medicines — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/create-medicines

Wikipedia (cite web)

{{cite web |title=CREATE Medicines — Funding & Investors |url=https://www.vcbacked.co/company/create-medicines |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 14, 2026.

Similar Companies in Biotechnology